A growing number of human immunodeficiency virus (HIV) patients are in need of new treatment as they start facing issues of drug resistance and their regular therapies are becoming less effective. Unfortunately, new treatment options are scarce to virtually non-existent, as the standard of care for HIV patients remains a combination of different classes of […]

Before the opening bell, Net Element, Inc. (NASDAQ: NETE) announced that its PayOnline subsidiary has entered into a new partnership with Sutochno.ru, Russia’s premier C2C short-term booking service, through which PayOnline will be providing online payment acceptance services for the platform. Similar to Airbnb, Sutochno.ru gives users the tools to book short-term accommodation in markets […]

GainClients, Inc. (OTC: GCLT) is disrupting the real estate marketing and advertising industry. Its GCard mobile technology platform ‘allows the loan originator, the real estate sales person, or the “title guy” to succeed in this marketplace’. In an interview with RedChip (http://dtn.fm/ez6tY), CEO of GainClients, Ray Desmond, discussed the concepts behind his company’s business model. […]

Cytosorbents Corp. (NASDAQ: CTSO), a critical care-focused immunotherapy company engaged in the research, development, and commercialization of medical devices, most prominently its platform blood purification technology that incorporates a proprietary adsorbent polymer technology, recently pre-announced unaudited results (http://dtn.fm/bKG3F) for fiscal 2016 ahead of its Form 10-K filing. Cytosorbents expects to announce between $8.1 and $8.3 […]

Rosetta Genomics, Ltd. (NASDAQ: ROSG), a company in the business of developing and commercializing MicroRNA-based and other molecular diagnostics, recently had its ‘Buy’ rating restated by Aegis Capital Corp. (http://dtn.fm/l0Yk0) with a price target of $3.50 per share. This was based on Aegis’ 2017 revenue estimate of $17.7 million with a multiple of 4X. The […]

Trevena, Inc. (NASDAQ: TRVN), a clinical stage biopharmaceutical company, on January 4 announced it had completed enrollment for its Phase 3 Apollo Pivotal Efficacy Trials of oliceridine for moderate to severe pain. Oliceridine (TRV 130) is Trevena’s lead product candidate. It was deemed “a breakthrough therapy by the U.S. Food and Drug Administration,” based on […]

Before the opening bell, eXp World Holdings, Inc. (OTCQB: EXPI) announced final 2016 agent totals for subsidiary eXp Realty LLC, the Agent-Owned Cloud Brokerage®. With 2,401 real estate brokers and agents on its platform at the end of the year, the company achieved a year-over-year increase of 178 percent, or 1,537 members, during 2016. This […]

Last month, a letter signed by 10 U.S. senators arrived on the desk of Jamal El-Hindi, the acting director of the Financial Crimes Enforcement Network (FinCEN), requesting guidance on how banking services might be offered to “indirect businesses” – such as SinglePoint, Inc. (OTC: SING), Medical Marijuana, Inc. (OTC: MJNA) and Cannabis Science, Inc. (OTC: […]

This year’s list of popular travel destinations is already quite varied and includes something for every demographic, from exciting adventures to classic cultural events and more. Whether it’s going on an African safari or visiting some of the oldest museums in Europe, tourists can easily organize their journeys with a little help from Monaker Group, […]

Jaguar Animal Health, Inc. (NASDAQ: JAGX), a company in the business of developing and commercializing gastrointestinal products for companion animals, horses, and production animals, recently had its company outlook updated by Aegis Capital Corp. (http://dtn.fm/Phj8l). The company has been offered a ‘Buy’ rating with a price target of $10 per share. The company update was […]